[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.179.146. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
From the Food and Drug Administration
March 7, 2001

Proposal for Public Disclosure About Clinical Trials

Author Affiliations
 

Not Available

Not Available

JAMA. 2001;285(9):1146. doi:10.1001/jama.285.9.1146-JFD10002-4-1

The FDA has posted a proposal to disclose certain public health and safety data involved in all new and ongoing clinical studies on gene therapy and xenotransplantation (http://www.fda.gov/ohrms/dockets/98FR/011801b.htm). The proposal is intended to ensure greater public confidence in new therapeutic technologies and make FDA policy for public access to this information compatible with those of other government agencies. Written comments may be submitted until April 18, 2001, to the Dockets Management Branch, FDA, 5630 Fishers Lane, Rockville, MD 20852.

First Page Preview View Large
First page PDF preview
First page PDF preview
×